240 related articles for article (PubMed ID: 33382189)
1. Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV co-infected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy.
Mohareb AM; Kouamé GM; Gabassi A; Gabillard D; Moh R; Badje A; Emième A; Maylin S; Ménan H; Hyle EP; Delaugerre C; Danel C; Anglaret X; Lacombe K; Eholié SP; Boyd A
J Viral Hepat; 2021 Apr; 28(4):621-629. PubMed ID: 33382189
[TBL] [Abstract][Full Text] [Related]
2. Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4
Kouamé GM; Gabillard D; Moh R; Badje A; Ntakpé JB; Emième A; Maylin S; Toni TD; Ménan H; Zoulim F; Danel C; Anglaret X; Eholié S; Lacombe K; Boyd A
Antivir Ther; 2021; 26(1-2):25-33. PubMed ID: 35485344
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.
Hoffmann CJ; Charalambous S; Martin DJ; Innes C; Churchyard GJ; Chaisson RE; Grant AD; Fielding KL; Thio CL
Clin Infect Dis; 2008 Dec; 47(11):1479-85. PubMed ID: 18937580
[TBL] [Abstract][Full Text] [Related]
5. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.
Coffie PA; Egger M; Vinikoor MJ; Zannou M; Diero L; Patassi A; Kuniholm MH; Seydi M; Bado G; Ocama P; Andersson MI; Messou E; Minga A; Easterbrook P; Anastos K; Dabis F; Wandeler G;
BMC Infect Dis; 2017 Nov; 17(Suppl 1):706. PubMed ID: 29143625
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.
Attia KA; Eholié S; Messou E; Danel C; Polneau S; Chenal H; Toni T; Mbamy M; Seyler C; Wakasugi N; N'dri-Yoman T; Anglaret X
World J Hepatol; 2012 Jul; 4(7):218-23. PubMed ID: 22855697
[TBL] [Abstract][Full Text] [Related]
7. HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy.
Malagnino V; Cerva C; Maffongelli G; Teti E; Foroghi Biland L; Cesta N; De Masi M; Stingone C; Armenia D; Svicher V; Salpini R; Andreoni M; Sarmati L
Sci Rep; 2019 Aug; 9(1):11942. PubMed ID: 31420570
[TBL] [Abstract][Full Text] [Related]
8. CD4
Li X; Xu L; Lu L; Liu X; Yang Y; Wu Y; Han Y; Li X; Li Y; Song X; Cao W; Li T
Front Cell Infect Microbiol; 2023; 13():1178788. PubMed ID: 37207191
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
Wandeler G; Musukuma K; Zürcher S; Vinikoor MJ; Llenas-García J; Aly MM; Mulenga L; Chi BH; Ehmer J; Hobbins MA; Bolton-Moore C; Hoffmann CJ; Egger M;
PLoS One; 2016; 11(3):e0152043. PubMed ID: 27032097
[TBL] [Abstract][Full Text] [Related]
11. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings.
Stabinski L; OʼConnor S; Barnhart M; Kahn RJ; Hamm TE
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S274-85. PubMed ID: 25768867
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Hepatitis B Virus Infection in HIV-Infected and HIV-Uninfected Participants Enrolled in a Multinational Clinical Trial: HPTN 052.
Greer AE; Ou SS; Wilson E; Piwowar-Manning E; Forman MS; McCauley M; Gamble T; Ruangyuttikarn C; Hosseinipour MC; Kumarasamy N; Nyirenda M; Grinsztejn B; Pilotto JH; Kosashunhanan N; Gonçalves de Melo M; Makhema J; Akelo V; Panchia R; Badal-Faesen S; Chen YQ; Cohen MS; Eshleman SH; Thio CL; Valsamakis A
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):388-393. PubMed ID: 28749822
[TBL] [Abstract][Full Text] [Related]
16. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
17. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.
Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM
J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
[TBL] [Abstract][Full Text] [Related]
19. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and clinical characteristics of hepatitis B virus in HIV-infected patients in Guangdong, China.
Huang SM; Cai WP; Hu FY; Lan Y; Liao BL; Chen YP; Tang XP
Int J STD AIDS; 2016 Sep; 27(10):890-7. PubMed ID: 26384940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
